Behavioral Science in Pharma: How AI and Evidence-Based Insight Are Transforming Industries

Intro

Behavioral science is reshaping how organizations understand and influence people — from customers and employees to patients and partners. By replacing assumptions with evidence-based insight, it drives better decisions, improved experiences, and stronger strategies.

Pharma has emerged as a proving ground for behavioral science — showing how understanding human behavior can boost compliance, innovation, and real-world impact.

In our recent webinar, Applying Behavioral Science in Pharma – Lessons for All Industries, we explored what makes pharma such fertile ground, what lessons translate across sectors, and how AI is accelerating the next wave of behavioral innovation.

The session features Antoine Perere, Co-Founder & CEO of lumenx.ai and President of the Behavioral AI Institute, and Julien Delearde, Pharma Leader in GxP Compliance and Behavioral Science — as they reveal how data, psychology, and technology are redefining the future of decision-making.

What you’ll learn

• Why pharma has become a proving ground for behavioral science
• Examples of behavioral science in action within pharma
• Principles that transfer across industries
• Misconceptions that hold back adoption
• AI and what’s next for behavioral science

If you’re a behavioral science professional, insight leader, or business decision-maker who wants to learn how pharma is pioneering the use of behavioral science—and how you can adapt these insights to accelerate outcomes in your own field, watch the webinar and download the report today.

Get the key highlights and expert insights from the session, including:

• Why Behavioral Science Matters More Than Ever in Pharma
• The Future of Behavioral Science: AI and Beyond
• Quick Insights: Biases, Books, and Takeaways

Download the Report: Behavioral Science in Pharma